Matt Chrysler

Matt Chrysler is the current head of portfolio and alliance management at TRex Bio. Matt has held this position for 3 years and 2 months. Prior to TRex Bio, Matt worked at Ultragenyx Pharmaceutical Inc. for 2 years and 10 months where they held titles such as new product planning and global commercial lead. Before Ultragenyx, Matt worked at Genentech for 6 years and 1 month where they were a strategy lead for Esbriet on the global oncology strategy team, biosimilar competitive readiness taskforce, and pipeline & portfolio planning. Matt has also been a manager at ZS for 5 years and 8 months.

Matt Chrysler has a Bachelor of Science from the University of Washington in Microbiology, a Master of Science from Georgetown University in Biochemistry and Molecular Biology, and a Master of Business Administration from Georgetown University's McDonough School of Business.